ALPEK (ALPEKA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Dec, 2025Executive summary
Comparable EBITDA for 2024 reached $699 million, surpassing both original and revised guidance by up to 17%, driven by higher container freight costs, stable reference margins, and disciplined capital allocation.
Key initiatives included cost reduction, operational efficiency, and a disciplined capital allocation strategy, generating $104 million in free cash flow.
Achieved $75 million in cost savings for 2024; further actions, including the Beaver Valley EPS facility closure, are expected to bring annualized savings to $100 million by mid-2025.
Focused on deleveraging, with leverage ratio reduced to 2.9x and a target of 2.5x, positioning for gradual industry recovery.
Financial highlights
Full-year volume rose 2% year-over-year to 4.75 million tons, with Q4 volume at 1.12 million tons, down 8% sequentially due to seasonality.
Q4 comparable EBITDA was $168 million; reported EBITDA was $109 million, up 106% year-over-year, impacted by a $52 million negative inventory adjustment.
Full-year reported EBITDA was $646 million; dividend yield reached 9%, with total payments of up to $170 million.
Net debt at year-end was $1.88 billion, with a net debt-to-EBITDA ratio of 2.9x, down from 3.7x at the start of the year.
Operating free cash flow for the year was $104 million; full-year CAPEX was $121 million, 19% below revised guidance.
Outlook and guidance
2025 guidance assumes stable demand and reference margins, with Asian PET margins at $270/ton and a 2% volume increase.
Comparable EBITDA for 2025 is projected at $625 million, reflecting lower expected container freight costs.
Annual CapEx is projected at $150 million, with $100 million for maintenance and $50 million for strategic projects, including EPS expansion in North America and PET sheet capacity in the Middle East.
No material investment in working capital is anticipated for 2025, supporting higher operating cash flow despite lower EBITDA.
2025 priorities include further structural cost reductions, cash flow generation, and balance sheet strength.
Latest events from ALPEK
- 2026 guidance targets $450–$500M EBITDA, with deleveraging and cost controls prioritized.ALPEKA
Q4 202511 Feb 2026 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 20242 Feb 2026 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 202418 Jan 2026 - EBITDA and revenue fell YoY, but cash flow and strategic initiatives advanced.ALPEKA
Q1 202527 Dec 2025 - Lower earnings and revised guidance amid global oversupply, tariffs, and operational disruptions.ALPEKA
Q2 202516 Nov 2025 - EBITDA and cash flow rose sequentially, but oversupply and lower prices pressured guidance.ALPEKA
Q3 202523 Oct 2025